Xstim earned FDA premarket application approval for its spine fusion stimulator, the company said April 16.
The Xstim device uses a low-energy signal to promote bone healing after spinal fusions, according to a news release. It is noninvasive and designed to streamline patient therapy management.
The device is expected to hit the market in the second quarter.